S. 3697: A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.
Sponsors
31 bill sponsors
-
TrackCindy Hyde-Smith
Sponsor
-
TrackJim Banks
Co-Sponsor
-
TrackMarsha Blackburn
Co-Sponsor
-
TrackKatie Boyd Britt
Co-Sponsor
-
TrackTed Budd
Co-Sponsor
-
TrackBill Cassidy
Co-Sponsor
-
TrackJohn Cornyn
Co-Sponsor
-
TrackTom Cotton
Co-Sponsor
-
TrackKevin Cramer
Co-Sponsor
-
TrackMike Crapo
Co-Sponsor
-
TrackTed Cruz
Co-Sponsor
-
TrackSteve Daines
Co-Sponsor
-
TrackJoni Ernst
Co-Sponsor
-
TrackDeb Fischer
Co-Sponsor
-
TrackLindsey Graham
Co-Sponsor
-
TrackBill Hagerty
Co-Sponsor
-
TrackJosh Hawley
Co-Sponsor
-
TrackJohn Hoeven
Co-Sponsor
-
TrackJohn Kennedy
Co-Sponsor
-
TrackJames Lankford
Co-Sponsor
-
TrackMike Lee
Co-Sponsor
-
TrackCynthia M. Lummis
Co-Sponsor
-
TrackRoger Marshall
Co-Sponsor
-
TrackMitch McConnell
Co-Sponsor
-
TrackJerry Moran
Co-Sponsor
-
TrackPete Ricketts
Co-Sponsor
-
TrackJames E. Risch
Co-Sponsor
-
TrackMike Rounds
Co-Sponsor
-
TrackRick Scott
Co-Sponsor
-
TrackRoger F. Wicker
Co-Sponsor
-
TrackTodd Young
Co-Sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Jan. 27, 2026 | Introduced in Senate |
| Jan. 27, 2026 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S292) |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.